QNCX

NASDAQStock

Quince Therapeutics, Inc.

$0.10-0.01 (-5.16%)

52-Week Range

$0.10

$4.40

Key Stats

Market Cap

5.6M

P/E Ratio

—

Dividend Yield

—

Beta

1.27

Volume

13.8M

Avg Volume

49.8M

Performance

-52.77%

-97.18%

-93.34%

YTD

-96.45%

-92.60%

-87.48%

-94.70%

Price Chart

ETF Exposure

QNCX is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	73	$16	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,612	$601	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$2	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,487,584	$253K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,824	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	674	$155	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	461,477	$78K	$84.10B	0.05%

About QNCX ETF Exposure

Quince Therapeutics, Inc. (QNCX) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 5.6M, QNCX is a widely held institutional stock. The stock currently trades at $0.10. Investors can gain exposure to QNCX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold QNCX, sorted by portfolio weight.